We are delighted that Boehringer Ingelheim, GlaxoSmithKline and Merck KGaA have pledged £7.5 million to allow the University of Dundee’s Division of Signal Transduction Therapy (DSTT) to continue its collaborative work.
The DSTT comprises 23 research teams at Dundee’s School of Life Sciences, 13 of which are based within the MRC PPU.
…more